Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery

Background This study was undertaken to investigate the growth rate and clinical outcome of patients with a small renal mass (SRM) after delayed surgery. Methods We reviewed the clinical records of 34 patients with SRMs ≤ 4 cm at diagnosis, who underwent delayed surgical intervention during surveillance from January 2000 to December 2011. Radiographic evaluations using computed tomography (CT) scan and magnetic resonance imaging (MRI) were performed at least every 6 months, and the tumor size was determined at least twice. Results The mean follow-up time was 26.6 ± 18.6 months and mean tumor doubling time was 23.4 ± 16.0 months. Histopathological analysis revealed that 32 of the 34 patients were malignant in pT1aN0M0. Only one patient showed tumor recurrence, who subsequently died due to tumor progression. Conclusion The growth rate of the small renal mass was slow in the majority of our patients. Delayed intervention does not have a detrimental effect on cancer-specific outcomes.

[1]  R. Uzzo,et al.  Active surveillance of small renal masses , 2013, Nature Reviews Urology.

[2]  B. Lane,et al.  Growth kinetics and active surveillance for small renal masses , 2012, Current opinion in urology.

[3]  Md. Shad Akhtar,et al.  Active surveillance of small renal masses offers short‐term oncological efficacy equivalent to radical and partial nephrectomy , 2012, BJU international.

[4]  R. Thompson,et al.  Approach to the small renal mass: to treat or not to treat. , 2012, The Urologic clinics of North America.

[5]  R. Uzzo,et al.  Small renal masses progressing to metastases under active surveillance , 2012, Cancer.

[6]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[7]  L. Klotz,et al.  Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. , 2011, European urology.

[8]  J. Richie,et al.  A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. , 2010, European urology.

[9]  J. Patard,et al.  Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. , 2009, The Journal of urology.

[10]  S. Boorjian,et al.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance , 2009, Cancer.

[11]  K. Bensalah,et al.  A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. , 2009, European urology.

[12]  O. Hes,et al.  Tumours in end-stage kidney. , 2008, Transplantation proceedings.

[13]  R. Uzzo,et al.  Predicting growth of solid renal masses under active surveillance. , 2008, Urologic oncology.

[14]  M. Kattan,et al.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer. , 2008, The Journal of urology.

[15]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[16]  R. Uzzo,et al.  Enhancing renal masses with zero net growth during active surveillance. , 2007, The Journal of urology.

[17]  Rebecca M. Lindell,et al.  Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. , 2007, Radiology.

[18]  S. Bhayani,et al.  Pathological features of renal neoplasms classified by size and symptomatology. , 2006, The Journal of urology.

[19]  H. Klingler,et al.  Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. , 2006, The Journal of urology.

[20]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[21]  J. Lam,et al.  Changing concepts in the surgical management of renal cell carcinoma. , 2004, European urology.

[22]  K. Marumo,et al.  Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. , 2004, Japanese journal of clinical oncology.

[23]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[24]  P. Warde,et al.  Impact of Noninvasive Imaging on Increased Incidental Detection of Renal Cell Carcinoma , 2000, European Urology.

[25]  M. Uder,et al.  [Value of ultrasound in early diagnosis of renal cell carcinoma]. , 2000, Der Urologe. Ausg. A.

[26]  A. Novick,et al.  Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.

[27]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[28]  H. Kosmehl,et al.  Increase of Renal Cell Carcinoma Incidence in Central Europe , 1998, European Urology.

[29]  A. Heidland,et al.  Cancer in End-Stage Renal Disease: Potential Factors Involved , 1998, American Journal of Nephrology.

[30]  A. Cassoni Tnm Classification of Malignant Tumours , 1987 .

[31]  Mordecai Schwartz A biomathematical approach to clinical tumor growth , 1961, Cancer.

[32]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[33]  J. Lynch,et al.  Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. , 2002, The Journal of urology.

[34]  P. Choyke,et al.  Acquired cystic kidney disease , 2000, European Radiology.